{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:07:42Z","timestamp":1791544062802,"version":"4.3.4"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The dopaminergic partial agonism of the so-called third-generation antipsychotics (TGAs; aripiprazole, brexpiprazole, cariprazine) is hypothesized to cause impulse control disorders (ICDs). Relevant warnings by the Food and Drug Administration (FDA) were posted on aripiprazole (2016) and brexpiprazole (2018). Our study investigated the FDA Adverse Event Reporting System and the pharmacodynamic CHEMBL database to further characterize TGA-induced ICDs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We downloaded and pre-processed the FDA Adverse Event Reporting System up to December 2020. We adapted Bradford Hill criteria to assess each TGA\u2019s \u2014and secondarily other antipsychotics\u2019\u2014causal role in inducing ICDs (pathological gambling, compulsive shopping, hyperphagia, hypersexuality), accounting for literature and disproportionality. ICD clinical features were analyzed, and their pathogenesis was investigated using receptor affinities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 2708 reports of TGA-related ICDs were found, primarily recording aripiprazole (2545 reports, 94%) among the drugs, and gambling (2018 reports, 75%) among the events. Bradford-Hill criteria displayed evidence for a causal role of each TGA consistent across subpopulations and when correcting for biases. Significant disproportionalities also emerged for lurasidone with compulsive shopping, hyperphagia, and hypersexuality, and olanzapine and ziprasidone with hyperphagia. Time to onset varied between days and years, and positive dechallenge was observed in 20% of cases. Frequently, co-reported events were economic (50%), obsessive-compulsive (44%), and emotional conditions (34%). 5-Hydroxytryptamine receptor type 1a agonism emerged as an additional plausible pathogenetic mechanism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We detected an association between TGAs and ICDs and identified a new signal for lurasidone. ICD characteristics are behavior specific and may heavily impact on life. The role of 5-Hydroxytryptamine receptor type 1a agonism should be further explored.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ijnp\/pyac031","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T15:34:48Z","timestamp":1654011288000},"page":"727-736","source":"Crossref","is-referenced-by-count":35,"title":["Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System"],"prefix":"10.1093","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0254-2212","authenticated-orcid":false,"given":"Michele","family":"Fusaroli","sequence":"first","affiliation":[{"name":"Pharmacology Unit, Department of Medical and Surgical Sciences, University of Bologna , Bologna , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuel","family":"Raschi","sequence":"additional","affiliation":[{"name":"Pharmacology Unit, Department of Medical and Surgical Sciences, University of Bologna , Bologna , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Giunchi","sequence":"additional","affiliation":[{"name":"Pharmacology Unit, Department of Medical and Surgical Sciences, University of Bologna , Bologna , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Menchetti","sequence":"additional","affiliation":[{"name":"Pharmacology Unit, Department of Medical and Surgical Sciences, University of Bologna , Bologna , Italy"},{"name":"Department of Biomedical and Neuromotor Sciences, University of Bologna , Bologna , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Rimondini Giorgini","sequence":"additional","affiliation":[{"name":"Pharmacology Unit, Department of Medical and Surgical Sciences, University of Bologna , Bologna , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"De Ponti","sequence":"additional","affiliation":[{"name":"Pharmacology Unit, Department of Medical and Surgical Sciences, University of Bologna , Bologna , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Poluzzi","sequence":"additional","affiliation":[{"name":"Pharmacology Unit, Department of Medical and Surgical Sciences, University of Bologna , Bologna , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,5,27]]},"reference":[{"key":"2022092803381413400_CIT0001","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.euroneuro.2020.03.022","article-title":"The association between receptor binding affinity and metabolic side effect profile of antipsychotics and major cardio- and cerebrovascular events: a case\/non-case study using VigiBase","volume":"35","author":"Aguiar","year":"2020","journal-title":"Eur Neuropsychopharmacol"},{"key":"2022092803381413400_CIT0002","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pharmthera.2018.06.012","article-title":"Molecular targets of atypical antipsychotics: from mechanism of action to clinical differences","volume":"192","author":"Aringhieri","year":"2018","journal-title":"Pharmacol Ther"},{"key":"2022092803381413400_CIT0003","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/ajmg.b.31025","article-title":"Significant association between the C(-1019)G functional polymorphism of the HTR1A gene and impulsivity","volume":"153B","author":"Benko","year":"2010","journal-title":"Am J Med Genet Part B Neuropsychiatr Genet"},{"key":"2022092803381413400_CIT0004","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1007\/s00415-021-10724-1","article-title":"Risk factors of impulsive-compulsive behaviors in PD patients: a meta-analysis","volume":"269","author":"Cao","year":"2021","journal-title":"J Neurol"},{"key":"2022092803381413400_CIT0005","volume-title":"FDA Drug Safety Communication: FDA warns about new impulse-control problems associated with mental health drug aripiprazole","author":"Center for Drug Evaluation and Research","year":"2019"},{"key":"2022092803381413400_CIT0006","doi-asserted-by":"crossref","first-page":"113168","DOI":"10.1016\/j.bbr.2021.113168","article-title":"Safety of antipsychotic drugs: a systematic review of disproportionality analysis studies","volume":"404","author":"Cepaityte","year":"2021","journal-title":"Behav Brain Res"},{"key":"2022092803381413400_CIT0007","doi-asserted-by":"crossref","first-page":"135555","DOI":"10.1016\/j.neulet.2020.135555","article-title":"Role of 5-HT1A receptor-mediated serotonergic transmission in the medial prefrontal cortex in acute restraint stress-induced augmentation of rewarding memory of cocaine in mice","volume":"743","author":"Chu","year":"2021","journal-title":"Neurosci Lett"},{"key":"2022092803381413400_CIT0008","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/1467-9566.13008","article-title":"Gender norms and social norms: differences, similarities and why they matter in prevention science","volume":"42","author":"Cislaghi","year":"2020","journal-title":"Sociol Health Illn"},{"key":"2022092803381413400_CIT0009","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neurol.2018.07.009","article-title":"Impulse control disorders in Parkinson disease: a cross-sectional study in Morocco","volume":"175","author":"El Otmani","year":"2019","journal-title":"Rev Neurol (Paris)"},{"key":"2022092803381413400_CIT0010","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/JCP.0000000000000634","article-title":"Risk of gambling disorder and impulse control disorder with aripiprazole, pramipexole, and ropinirole: a pharmacoepidemiologic study","volume":"37","author":"Etminan","year":"2017","journal-title":"J Clin Psychopharmacol"},{"key":"2022092803381413400_CIT0011","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/mds.27689","article-title":"Scales to assess impulsive and compulsive behaviors in Parkinson\u2019s disease: critique and recommendations","volume":"34","author":"Evans","year":"2019","journal-title":"Mov Disord"},{"key":"2022092803381413400_CIT0012","author":"FDA","year":"2022"},{"key":"2022092803381413400_CIT0013","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.parkreldis.2021.08.006","article-title":"Impulsive conditions in Parkinson\u2019s disease: a pharmacosurveillance-supported list","volume":"90","author":"Fusaroli","year":"2021","journal-title":"Parkinsonism Relat Disord"},{"key":"2022092803381413400_CIT0014","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/JCP.0000000000001411","article-title":"The impact of serotonin transporter binding affinity on the risk of bleeding related to antidepressants","volume":"41","author":"Gahr","year":"2021","journal-title":"J Clin Psychopharmacol"},{"key":"2022092803381413400_CIT0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000510703","article-title":"Post-marketing safety concerns with esketamine: a disproportionality analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System","volume":"90","author":"Gastaldon","year":"2021","journal-title":"Psychother Psychosom"},{"key":"2022092803381413400_CIT0016","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/s41386-019-0590-6","article-title":"A positron emission tomography occupancy study of brexpiprazole at dopamine D2 and D3 and serotonin 5-HT1A and 5-HT2A receptors, and serotonin reuptake transporters in subjects with schizophrenia","volume":"45","author":"Girgis","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"2022092803381413400_CIT0017","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/JCP.0000000000000444","article-title":"Pathological gambling associated with aripiprazole or dopamine replacement therapy","volume":"36","author":"Grall-Bronnec","year":"2016","journal-title":"J Clin Psychopharmacol"},{"key":"2022092803381413400_CIT0018","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40264-017-0590-6","article-title":"Dopamine agonists and impulse control disorders: a complex association","volume":"41","author":"Grall-Bronnec","year":"2018","journal-title":"Drug Saf"},{"key":"2022092803381413400_CIT0019","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/WNR.0b013e328352de40","article-title":"5-HT1A and 5-HT7 receptors contribute to lurasidone-induced dopamine efflux","volume":"23","author":"Huang","year":"2012","journal-title":"Neuroreport"},{"key":"2022092803381413400_CIT0020","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00213-020-05496-x","article-title":"Effects of 5-HT2C, 5-HT1A receptor challenges and modafinil on the initiation and persistence of gambling behaviours","volume":"237","author":"Humby","year":"2020","journal-title":"Psychopharmacology (Berl)"},{"key":"2022092803381413400_CIT0021","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s40263-020-00718-4","article-title":"Comparative tolerability of dopamine D2\/3 receptor partial agonists for schizophrenia","volume":"34","author":"Keks","year":"2020","journal-title":"CNS Drugs"},{"key":"2022092803381413400_CIT0022","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/YIC.0000000000000194","article-title":"Aripiprazole and impulse control disorders: higher risk with the intramuscular depot formulation?","volume":"33","author":"Lertxundi","year":"2018","journal-title":"Int Clin Psychopharmacol"},{"key":"2022092803381413400_CIT0023","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00213-003-1726-1","article-title":"Effects of acute and chronic buspirone on impulsive choice and efflux of 5-HT and dopamine in hippocampus, nucleus accumbens and prefrontal cortex","volume":"173","author":"Liu","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"2022092803381413400_CIT0024","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.neulet.2013.10.013","article-title":"Acute and subchronic effects of buspirone on attention and impulsivity in the five-choice serial reaction time task in rats","volume":"556","author":"Lu","year":"2013","journal-title":"Neurosci Lett"},{"key":"2022092803381413400_CIT0025","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ajp.2016.08.001","article-title":"Aripiprazole induced impulse control disorders: where do we stand?","volume":"23","author":"Mahapatra","year":"2016","journal-title":"Asian J Psychiatry"},{"key":"2022092803381413400_CIT0026","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.3389\/fneur.2018.01018","article-title":"Dopaminergic neurotransmission in patients with Parkinson\u2019s disease and impulse control disorders: a systematic review and meta-analysis of PET and SPECT Studies","volume":"9","author":"Martini","year":"2018","journal-title":"Front Neurol"},{"key":"2022092803381413400_CIT0027","doi-asserted-by":"crossref","first-page":"9113","DOI":"10.1038\/s41598-021-88462-7","article-title":"Vortioxetine ameliorates anhedonic-like behaviour and promotes strategic cognitive performance in a rodent touchscreen task","volume":"11","author":"Martis","year":"2021","journal-title":"Sci Rep"},{"key":"2022092803381413400_CIT0028","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s40263-019-00631-5","article-title":"Association of hyponatraemia and antidepressant drugs: a pharmacovigilance-pharmacodynamic assessment through an analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS) database","volume":"33","author":"Mazhar","year":"2019","journal-title":"CNS Drugs"},{"key":"2022092803381413400_CIT0029","doi-asserted-by":"crossref","first-page":"D930","DOI":"10.1093\/nar\/gky1075","article-title":"ChEMBL: towards direct deposition of bioassay data","volume":"47","author":"Mendez","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2022092803381413400_CIT0030","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1001\/jamainternmed.2014.5262","article-title":"Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs","volume":"174","author":"Moore","year":"2014","journal-title":"JAMA Intern Med"},{"key":"2022092803381413400_CIT0031","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1517\/14740338.2015.974549","article-title":"Weight gain and antipsychotics: a drug safety review","volume":"14","author":"Musil","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"2022092803381413400_CIT0032","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1254\/jphs.12264FP","article-title":"Tandospirone suppresses impulsive action by possible blockade of the 5-HT1A receptor","volume":"122","author":"Ohmura","year":"2013","journal-title":"J Pharmacol Sci"},{"key":"2022092803381413400_CIT0033","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1080\/14740338.2020.1795126","article-title":"Up-to-date expert opinion on the safety of recently developed antipsychotics","volume":"19","author":"Orsolini","year":"2020","journal-title":"Expert Opin Drug Saf"},{"key":"2022092803381413400_CIT0034","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/mdc3.13128","article-title":"Does the country make a difference in impulse control disorders? A systematic review","volume":"8","author":"Parra-D\u00edaz","year":"2020","journal-title":"Mov Disord Clin Pract"},{"key":"2022092803381413400_CIT0035","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s40264-013-0032-z","article-title":"Antipsychotics and torsadogenic risk: signals emerging from the US FDA Adverse Event Reporting System database","volume":"36","author":"Poluzzi","year":"2013","journal-title":"Drug Saf"},{"key":"2022092803381413400_CIT0036","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10549-020-06001-w","article-title":"Cyclin-dependent kinase 4\/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment","volume":"186","author":"Raschi","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"2022092803381413400_CIT0037","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/JCP.0000000000000934","article-title":"A case of hypersexuality probably associated with lurasidone","volume":"38","author":"Reddy","year":"2018","journal-title":"J Clin Psychopharmacol"},{"key":"2022092803381413400_CIT0038","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.parkreldis.2013.02.007","article-title":"Pathological gambling in Parkinson\u2019s disease. A comprehensive review","volume":"19","author":"Santangelo","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"2022092803381413400_CIT0039","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/syn.21805","article-title":"Parkinson\u2019s disease treatment may cause impulse\u2013control disorder via dopamine D3 receptors","volume":"69","author":"Seeman","year":"2015","journal-title":"Synapse"},{"key":"2022092803381413400_CIT0040","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00213-014-3704-1","article-title":"Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission","volume":"232","author":"Snyder","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"2022092803381413400_CIT0041","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/10615806.2020.1722597","article-title":"A neuroeconomic investigation of 5-HTT\/5-HT1A gene variation, social anxiety, and risk-taking behavior","volume":"33","author":"Stamatis","year":"2020","journal-title":"Anxiety Stress Coping"},{"key":"2022092803381413400_CIT0042","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients","volume":"67","author":"Weintraub","year":"2010","journal-title":"Arch Neurol"},{"key":"2022092803381413400_CIT0043","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.euroneuro.2021.05.001","article-title":"Do cariprazine and brexpiprazole cause impulse control symptoms? A case\/non-case study","volume":"50","author":"Zazu","year":"2021","journal-title":"Eur Neuropsychopharmacol"}],"container-title":["International Journal of Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ijnp\/advance-article-pdf\/doi\/10.1093\/ijnp\/pyac031\/44250217\/pyac031.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijnp\/article-pdf\/25\/9\/727\/46107215\/pyac031.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijnp\/article-pdf\/25\/9\/727\/46107215\/pyac031.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T23:39:12Z","timestamp":1664321952000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijnp\/article\/25\/9\/727\/6593999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,27]]},"references-count":43,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,5,27]]},"published-print":{"date-parts":[[2022,9,28]]}},"URL":"https:\/\/doi.org\/10.1093\/ijnp\/pyac031","relation":{},"ISSN":["1461-1457","1469-5111"],"issn-type":[{"value":"1461-1457","type":"print"},{"value":"1469-5111","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,9,1]]},"published":{"date-parts":[[2022,5,27]]}}}